News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major headlines emerged in the past hour; global news flow was quiet.
  • Equity markets traded muted with low volume and limited price movement.
  • U.S. Treasury yields were little changed amid an absence of fresh economic data.
  • The dollar held near prior levels with minimal intraday volatility.
  • Oil and gold posted muted moves with no new supply or demand catalysts reported.
  • No policy statements from major central banks or governments were released in the hour.

Latest Articles

Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum

Descartes To Showcase Supply Chain and Logistics AI and Technology Innovations at 2026 Innovation Forum

Descartes Systems Group announced that it will showcase cutting-edge AI and logistics technology innovations designed to streamline supply chain operations at its 2026 Innovation Forum in Chicago. The technologies include AI-driven transportation management, fleet performance optimization, global trade intelligence, and ecommerce operations enhance…

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company (Nasdaq: SGMT), announced it priced an underwritten offering of Series A common stock and pre-funded warrants, raising approximately $115 million before expenses. The company plans to use the proceeds to fund a Phase 3 clinical trial for denifanstat in acne, support pre-launch act…

Mizuho After the BOJ Shift: Buy the Yield Rebound, Hold for 180 Days

Mizuho After the BOJ Shift: Buy the Yield Rebound, Hold for 180 Days

Mizuho Financial (MFG) looks attractive after recent Bank of Japan tightening and management's investor day narrative. The stock trades near $11.07 with a reasonable P/E of 15.2 and PB of 1.9, a dividend yield of ~1.26%, and a market cap around $135.8B. We lay out a long trade with an entry at $11.00, a stop at $10.20 and a $12.50 target over a 180…

Beam Global to Present Advanced Battery Technology for AI Data Centers and Electric Aviation at The Battery Show North America

Beam Global to Present Advanced Battery Technology for AI Data Centers and Electric Aviation at The Battery Show North America

Beam Global announced it will present its advanced battery technologies targeting high-power applications such as AI data centers and electric vertical takeoff and landing (eVTOL) aircraft at The Battery Show North America. The company highlighted its proprietary thermal management innovations designed to handle extreme power fluctuations and batte…

Cal-Maine Foods Reports First Quarter Fiscal 2027 Results

Cal-Maine Foods Reports First Quarter Fiscal 2027 Results

Cal-Maine Foods, the largest U.S. egg producer, reported a 41.5% drop in net sales and a net loss of $58.6 million in Q1 fiscal 2027 compared to a profit in the prior year. The decline was driven by a substantial fall in conventional shell egg prices due to market oversupply, despite stable volume. Specialty shell eggs and Prepared Foods now repres…

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Sagimet Biosciences announced positive 52-week data from Ascletis' Phase 3 open-label extension trial of denifanstat, an oral FASN inhibitor for moderate to severe acne vulgaris. The results demonstrated sustained efficacy with a 57% treatment success rate and significant reduction in lesion counts, while maintaining a favorable safety profile. Sag…

Sezzle Upgrade: Why the Marketing Drag Is Turning into an Opportunity

Sezzle Upgrade: Why the Marketing Drag Is Turning into an Opportunity

Sezzle's recent results and guidance show marketing ROI that supports profitable growth. Active subscribers jumped 76% YoY, revenue rose 51.7% in Q2 2026 and the company retains strong payback metrics. Technicals and short interest create a favorable risk/reward. I upgrade the rating and lay out an actionable long trade with entry, stop and targets…

Alaska LNG Faces Uncertainty Despite Potential $54 Billion Investment Push

Alaska LNG Faces Uncertainty Despite Potential $54 Billion Investment Push

Plans to accelerate the Alaska LNG project have resurfaced as the administration considers tapping a roughly $54 billion South Korean strategic investment pledge. The greenfield effort would move North Slope gas through an 800-mile pipeline to a liquefaction terminal at Nikiski, targeting first exports in 2031, but concerns persist over cost, devel…

Western Digital: Buy the Real Storage Play While the NAND Hype Runs Hot

Western Digital: Buy the Real Storage Play While the NAND Hype Runs Hot

Western Digital (WDC) is a pragmatic way to play AI-driven storage demand without paying top-tier flash multiples. The company reported strong fiscal 2026 free cash flow ($3.51B), a modest net cash position (~$500M), and returned $3.1B to shareholders. With a market cap near $163.6B and a PE ~17.5x, WDC offers a mid-term asymmetric trade: buy on we…

UnitedHealth: Fundamentals Are Healing — Time to Own the Recovery

UnitedHealth: Fundamentals Are Healing — Time to Own the Recovery

UnitedHealth Group's underlying recovery - better medical cost trends, stronger Optum performance, and rising analyst earnings estimates - is underappreciated by the market. The stock sits below key moving averages and shows an RSI in the high-30s despite robust free cash flow ($23.6B) and an enterprise value of $381.3B. This trade targets an entry…

Nearly US$100 trillion of investment will depend on decisions made under uncertainty, says new Willis report

Nearly US$100 trillion of investment will depend on decisions made under uncertainty, says new Willis report

Willis Towers Watson released a report emphasizing the complexity of strategic decision-making today, driven by overlapping investments in AI, electrification, and security competing for limited resources. The report offers a framework to improve leader's ability to recognize changing assumptions and act proactively to preserve value among nearly $…

Doha Mediators Deliver U.S. Feedback on Seven-Day Iran Trust Plan

Doha Mediators Deliver U.S. Feedback on Seven-Day Iran Trust Plan

Qatari mediators delivered U.S. feedback in Doha on a seven-day trust-building proposal between Washington and Tehran. Iranian Foreign Minister Abbas Araqchi received the response, with the main dispute focusing on the order in which steps would be implemented rather than their substance. Araqchi is due to brief Tehran on the U.S. reaction.